false

Jen Vance

Jen Vance is a Senior Director of Operational Strategy at Precision whose career spans over twenty years within the CRO industry. She has provided portfolio and departmental oversight, clinical development planning, therapeutic strategy and provision of therapeutic expertise. Jen has vetted drug development experience in phase I through IV hematology / oncology studies, with a specialized focus on hematologic malignancies, targeted therapies and immunotherapies.

• Read: Clinical Trial Trends: Non-malignant Hematology

  Clinical Trials

  Clinical Trial Trends: Non-malignant Hematology

  Jan 13, ‘25 | 4 min read

  • 

    Jen Vance

  Discover
• Read: Clinical Trial Trends: Non-Hodgkin’s Lymphoma

  Clinical Trials - Oncology

  Clinical Trial Trends: Non-Hodgkin’s Lymphoma

  Sep 24, ‘24 | 6 min read

  • 

    Jen Vance

  Discover
• Read: Clinical Trial Trends: Multiple Myeloma

  Clinical Trials - Oncology

  Clinical Trial Trends: Multiple Myeloma

  Aug 21, ‘24 | 6 min read

  • 

    Jen Vance

  Discover

Loading...

You've reach the end Back to top